We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Methods Evaluated for HER2 Status in Breast Cancer

By LabMedica International staff writers
Posted on 23 Sep 2013
Print article
Image: ABI Prism 7700 Sequence Detection System (Photo courtesy of Applied Biosystems).
Image: ABI Prism 7700 Sequence Detection System (Photo courtesy of Applied Biosystems).
The human epidermal growth factor receptor 2 gene (HER2) is overexpressed or amplified in approximately 15% to 20% of all breast cancers leading to a poorer prognosis.

This results in overexpression of the HER2 protein, which is associated with worse clinical outcomes in breast cancer patients, and therefore it is essential to achieve accurate assessment of HER2 status. This can be done at the DNA, messenger ribonucleic acid (mRNA), or protein level by several different methods.

Scientists at Linköping University (Sweden) analyzed 145 formalin-fixed paraffin-embedded (FFPE) primary breast cancer samples by real-time polymerase chain reaction (PCR) amplification of HER2, using amyloid precursor protein as a reference. The selection of tumor material was based on previous clinical testing of HER2, accomplished either solely by fluorescence in situ hybridization (FISH) for 145 tumors or by both immunohistochemistry (IHC) and FISH for 127 tumors.

The IHC staining for HER2 had been performed on 127 FFPE tumor samples, and this was achieved using the HercepTest (Dako, Glostrup, Denmark). The FISH was performed on 4-μm thick sections of FFPE tissue using the PathVysion HER-2 DNA Probe Kit (Abbott Laboratories; Abbott Park, IL, USA). All reactions for the real time PCR were performed with the ABI Prism 7700 Sequence Detection System (Applied Biosystems AB; Stockholm, Sweden).

The authors found that there was a concordance of 93% between real-time PCR and FISH, and 86% between real-time PCR and IHC. They concluded that real-time PCR is a rapid technique that does not require any sophisticated models to interpret the results. Furthermore, it is cost-effective, and many samples can be analyzed simultaneously. Real-time PCR can therefore be used to detect HER2 amplification in DNA from FFPE breast cancer tissue. The study was published on September 7, 2013, in the journal Pathology and Laboratory Medicine International.

Related Links:

Linköping University
Dako
Abbott Laboratories


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.